​

Mural Oncology (MURA) Stock Forecast, Price Target & Predictions

OverviewFinancialsChart

MURA Stock Rating

Mural Oncology stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 1 Strong Buy (25.00%), 3 Buy (75.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 3 1 Strong Sell Sell Hold Buy Strong Buy

MURA Price Target Upside V Benchmarks

TypeNameUpside
StockMural Oncology-
SectorHealthcare Stocks 25.10%
IndustryBiotech Stocks 61.24%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.27$4.27$4.27
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 2522---4
Jan, 2522---4
Dec, 2421---3
Nov, 2421---3
Oct, 2421---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 17, 2024H.C. WainwrightBuyinitialise
Oct 04, 2024Raymond JamesStrong Buyinitialise
Jun 28, 2024Rodman & RenshawBuyinitialise
Apr 04, 2024Morgan StanleyOverweightinitialise

Financial Forecast

EPS Forecast

$-8 $-7 $-6 $-5 $-4 $-3 $-2 $-1 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-----
Avg Forecast$-7.56$-4.86$-3.07$-2.59$-1.60
High Forecast$-7.53$-4.01$-3.07$-2.59$-1.60
Low Forecast$-7.61$-5.47$-3.07$-2.59$-1.60
Surprise %-----

Revenue Forecast

$10M $23M $36M $49M $62M $75M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-----
Avg Forecast--$10.18M$23.73M$71.55M
High Forecast--$10.18M$23.73M$71.55M
Low Forecast--$10.18M$23.73M$71.55M
Surprise %-----

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-----
Avg Forecast$-126.09M$-81.05M$-51.29M$-43.26M$-26.66M
High Forecast$-125.59M$-66.97M$-51.29M$-43.26M$-26.66M
Low Forecast$-126.93M$-91.36M$-51.29M$-43.26M$-26.66M
Surprise %-----

MURA Forecast FAQ

Is Mural Oncology stock a buy?

Mural Oncology stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Mural Oncology is a favorable investment for most analysts.

What is Mural Oncology's price target?

Mural Oncology's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $4.27.

How does Mural Oncology stock forecast compare to its benchmarks?

Mural Oncology's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (25.10%) and underperforming the biotech stocks industry (61.24%).

What is the breakdown of analyst ratings for Mural Oncology over the past three months?

  • February 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Mural Oncology’s EPS forecast?

Mural Oncology's average annual EPS forecast for its fiscal year ending in December 2024 is $-7.56, marking a 0% decrease from the reported - in 2023. Estimates for the following years are $-4.86 in 2025, $-3.07 in 2026, $-2.59 in 2027, and $-1.6 in 2028.

What is Mural Oncology’s revenue forecast?

Mural Oncology's average annual revenue forecast for its fiscal year ending in December 2024 is $0, reflecting a 0% decrease from the reported - in 2023. The forecast for 2025 is $0, followed by $10.18M for 2026, $23.73M for 2027, and $71.55M for 2028.

What is Mural Oncology’s net income forecast?

Mural Oncology's net income forecast for the fiscal year ending in December 2024 stands at $-126M, representing a 0% decrease from the reported - in 2023. Projections indicate $-81.053M in 2025, $-51.293M in 2026, $-43.264M in 2027, and $-26.662M in 2028.